FindTrial
Sign In

A study of fecal protein loosing in pediatric Kawasaki's disease patients.

A study of fecal protein loosing in pediatric Kawasaki's disease patients. - A study of fecal protein loosing in pediatric Kawasaki's disease patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030843
Enrollment
160
Registered
2018-04-01
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki&#39

Interventions

Enema twice for acupuncture (acute phase and remission phase), 1 dose is 2 ml / kg

Sponsors

Juntendo University, Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children of 0 to 6-year old at consent income. 2. Consent in writing has been obtained from the substitute for participation in the research. 3. Children which meets the diagnostic criteria of Kawasaki's disease.

Exclusion criteria

Exclusion criteria: 1. Children having chronic gastrointestinal diseases (inflammatory bowel disease, protein loosing enteropathy, etc.) from the prevalence of Kawasaki's disease. 2. Children having an operation history such as intestinal resection.

Design outcomes

Primary

MeasureTime frame
Changes in fecal alpha1-antitrypsin levels between the acute and remission phase of Kawasaki's disease—

Countries

Japan

Contacts

Public ContactKeisuke Jimbo

Juntendo University, Faculty of Medicine Department of Pediatrics

kjinbo@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026